Oncovet Clinical Research

About:

Oncovet Clinical Research develops medicine for human and animal illnesses.

Website: http://www.oncovet-clinical-research.com

Top Investors: Newfund, Eurasante

Description:

Oncovet Clinical Research is a French contract research organization that handles clinical trials on dogs and cats as test subjects for drugs designed for humans. OCR considers ethical standards in researches that involves animals, since they include experimental dogs and cats in new therapies developed for humans. OCR specializes in oncology, inflammation, cardiology, and neurology. It aims to help pharmaceutical organizations invent better medicines for many human illnesses. The company provides clinical trials in comparative medicine that allows for optimization of the drug discovery process and decrease of the attrition rate, as well as filling the gap between pre-clinical and phase I and II human studies. Dominique Tierny and François Serres founded Oncovet Clinical Research in 2011, based in Villeneuve-d'Ascq in France.

Total Funding Amount:

1.25M EUR

Headquarters Location:

Loos, Nord-Pas-de-Calais, France

Founded Date:

2011-01-01

Contact Email:

mdubruque(AT)oncovet-clinical-research.com

Founders:

Dominique Tierny, François Serres

Number of Employees:

11-50

Last Funding Date:

2016-09-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai